article thumbnail

Confessions of an Ad Writer: How I Helped Turn Atypical Antipsychotics into a Billion-Dollar Industry

Mad in America

I was just a copywriter working in pharmaceutical advertising. The rise of atypical antipsychotics was a business and marketing phenomenon—driven in part by a wave of pharmaceutical mergers in the 1990s. I didn’t set out to shape the field of psychiatry. The agency was in Midtown Manhattan. The client was Johnson & Johnson.

article thumbnail

is it weird to stretch at work, is declining a reference call a red flag, and more

Ask a Manager

I once supervised a young person who was fresh out of college and in his first full-time job. It was a healthcare-related nonprofit, and the articles indicated that the organization was funded and heavily influenced by corporate pharmaceutical companies despite portraying itself as an advocate for patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our Medical System Protects Wrongdoers and Punishes Whistleblowers: An Interview with Carl Elliott

Mad in America

An influential voice in bioethics, Elliott is known for his critical examination of the medical and pharmaceutical industries. The licensing board suspended his license for a short period of time, made him practice under the supervision of someone else, and ordered him to take an ethics course. I was stunned.

article thumbnail

On Not Becoming David Foster Wallace

Mad in America

First, I found a supervising psychiatrist with tapering experience, which is vanishingly rare in Australia. This is not to let the pharmaceutical companies, the government drug-approving bodies, and the doctors who write the scripts without thinking off the hook. There are no studies, not yet. I have no illusions about the road ahead.

article thumbnail

Context and Care vs. Isolate and Control: An Interview on the Dilemmas of Global Mental Heath with Arthur Kleinman

Mad in America

The middle class has come to understand genetics, biotechnology, and pharmaceuticals and is better educated in science and technology. Regarding treatments, you have yourself written that psycho-pharmaceuticals have been found to be a lot less effective and have severe adverse effects. the UK, and Canada into the Global South?

article thumbnail

Leaving Biological Psychiatry Behind: An Interview With Rodrigo Nardi

Mad in America

It’s five years of study and in the last year, you work as a psychologist under supervision. Medical school is six years and during the last one to two years, you work as a doctor under supervision. Siem: You don’t serve the pharmaceutical company who might be paying you on the side. You don’t serve the hospital.

article thumbnail

Much of U.S. Healthcare Is Broken: How to Fix It (Chapter 2, Part 7)

Mad in America

One of these studies, sponsored of course by a pharmaceutical company, was conducted by the Kansas University Medical School, Wichita branch, and I attended, along with a group of local psychologists, a presentation of this study in progress by one of the staff psychologists who was one of the researchers and CBT therapists.